Cannabidiol is a treatment option in children with severe refractory epilepsy
Epilepsy in children can be a part of Dravet syndrome and Lennox-Gastaut syndrome, but other epilepsy diagnoses are also present. The paper of Zilmer and Olofsson describes results of a quality control study of cannabidiol off-label treatment in 78 children and young adults with severe refractory epilepsy, which took place from 2016 to 2019 at the Paediatric Department, Filadelfia Epilepsy Hospital, Denmark.
Original Article 01/05
